A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine

Summary

The objective of this study is to evaluate the immunogenicity and safety of SCTV01C in participants aged ≥12 years and previously fully immunized with inactivated COVID-19 vaccine.

Timeline

Start

2022-04-25

Primary completion

2022-07-01

Completion

2023-02-01

Outcome

Outcome not reported

Stopped: “There was not a need to carry out a study in LAO any more.”

Drugs

Indications